相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity
Scott R. Walsh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Therapeutic T cell engineering
Michel Sadelain et al.
NATURE (2017)
Targeting neoantigens to augment antitumour immunity
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations
Eric Tran et al.
NATURE IMMUNOLOGY (2017)
Tracking the fate and origin of clinically relevant adoptively transferred CD8+ T cells in vivo
Aude G. Chapuis et al.
SCIENCE IMMUNOLOGY (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Mutational Landscape and Sensitivity to Immune Checkpoint Blockers
Roman M. Chabanon et al.
CLINICAL CANCER RESEARCH (2016)
T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression
Aude G. Chapuis et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination
Byram W. Bridle et al.
JOURNAL OF IMMUNOLOGY (2016)
Safety concerns blight promising cancer therapy
Heidi Ledford
NATURE (2016)
Engulfed cadherin fingers are polarized junctional structures between collectively migrating endothelial cells
Arnold Hayer et al.
NATURE CELL BIOLOGY (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Role of memory T cell subsets for adoptive immunotherapy
Dirk H. Busch et al.
SEMINARS IN IMMUNOLOGY (2016)
Towards a commercial process for the manufacture of genetically modified T cells for therapy
A. D. Kaiser et al.
CANCER GENE THERAPY (2015)
The Evolution of T-cell Therapies for Solid Malignancies
Kristen Fousek et al.
CLINICAL CANCER RESEARCH (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition
Roch Houot et al.
CANCER IMMUNOLOGY RESEARCH (2015)
An optimized peptide vaccine strategy capable of inducing multivalent CD8+ T cell responses with potent antitumor effects
Hyun-Il Cho et al.
ONCOIMMUNOLOGY (2015)
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins et al.
CLINICAL CANCER RESEARCH (2015)
Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy
Joseph G. Crompton et al.
IMMUNOLOGICAL REVIEWS (2014)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
Fei Duan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Maraba Virus as a Potent Oncolytic Vaccine Vector
Jonathan G. Pol et al.
MOLECULAR THERAPY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells
Seth M. Pollack et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Safety Studies on Intravenous Administration of Oncolytic Recombinant Vesicular Stomatitis Virus in Purpose-Bred Beagle Dogs
Amy K. LeBlanc et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2013)
Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Current Status and Future Outlook
Richard Wu et al.
CANCER JOURNAL (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe
David E. Gilham et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
Veronique Corbiere et al.
CANCER RESEARCH (2011)
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Caroline J. Breitbach et al.
NATURE (2011)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T Cells
Claudia Wrzesinski et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Potentiating Cancer Immunotherapy Using an Oncolytic Virus
Byram W. Bridle et al.
MOLECULAR THERAPY (2010)
Rapid Maturation of Effector T Cells in Tumors, but Not Lymphoid Organs, during Tumor Regression
Lyse A. Norian et al.
PLOS ONE (2007)
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8(+) T-cell response to reptide vaccination: Creation of a beneficial host microenvironment involving type IIFNs and myeloid cells
Mohamed L. Salem et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Increased intensity lymphodepletion and adoptive immunotherapy - how far can we go?
Pawel Muranski et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cutting edge: Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy
PF Robbins et al.
JOURNAL OF IMMUNOLOGY (2004)
CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ
S Radoja et al.
JOURNAL OF IMMUNOLOGY (2001)
Eradication of established tumors by CD8+ T cell adoptive immunotherapy
HL Hanson et al.
IMMUNITY (2000)
分享论文
